2011
DOI: 10.1016/j.neures.2011.05.019
|View full text |Cite
|
Sign up to set email alerts
|

GDNF-pretreatment enhances the survival of neural stem cells following transplantation in a rat model of Parkinson's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
26
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(28 citation statements)
references
References 25 publications
2
26
0
Order By: Relevance
“…3,4 Therefore, there are now active pursuits in the eld of tissue engineering to utilize biomaterials as scaffolds to assist stem cell survival and guided integration along with supplying sustained and localized biomolecules to injured CNS sites. [5][6][7] The eld of tissue engineering combines scaffolds, cells and regulatory molecules to create ideal bio-mimic microenvironments for restoring and regenerating injured body tissues. Currently, the materials used for fabrication of scaffolds in the eld mainly focused on naturally derived or synthetic ones.…”
Section: Introductionmentioning
confidence: 99%
“…3,4 Therefore, there are now active pursuits in the eld of tissue engineering to utilize biomaterials as scaffolds to assist stem cell survival and guided integration along with supplying sustained and localized biomolecules to injured CNS sites. [5][6][7] The eld of tissue engineering combines scaffolds, cells and regulatory molecules to create ideal bio-mimic microenvironments for restoring and regenerating injured body tissues. Currently, the materials used for fabrication of scaffolds in the eld mainly focused on naturally derived or synthetic ones.…”
Section: Introductionmentioning
confidence: 99%
“…Parkinson's disease is resulted from the loss of dopaminergic neurons in the substantia nigra1821. Stem cells express glial-cell-line-derived neurotrophic factor, which has been shown to improve the survival and function of dopaminergic neurons that may be one approach to stop the death of dopaminergic neurons2022. Furthermore, stem cells can generate cholinergic neurons to improve the cognitive function of Alzheimer's disease patients1819.…”
mentioning
confidence: 99%
“…Currently, many different types of stem cell can be cultured and transplanted, including induced pluripotent stem cells (iPS cells) (Takahashi & Yamanaka, 2006), embryonic stem cells (ES cells) (Wang et al, 2011), neural stem cells (NSCs) (Kameda et al, 2007;Muraoka et al, 2006) , mesenchymal stem cells (MSCs) (Kurozumi et al, 2004;Wang et al, 2010) , and hematopoietic stem cells (Shyu et al, 2006), and some of these have already been used in clinical trials. Every type of stem cell has unique advantages and disadvantages.…”
Section: Approaches To Regenerative Medicine For Cerebral Infarctionmentioning
confidence: 99%
“…During transplantation, stem cells are subject to hypoxic-ischemic injury. Wang et al showed that graft survival was enhanced by pretreatment with GDNF for three days before NSC transplantation (Wang et al, 2011). Because brain tissue architecture is disrupted in the ischemic brain, the use of biodegradable scaffolds may help transplanted stem cells regenerate and/or restore damaged brain structures and functions, by affecting cell differentiation, morphology, adhesion, or gene expression (Kleinman & Martin, 2005;Steindler, 2002).…”
Section: Graft Survivalmentioning
confidence: 99%